IGF2BP2 and clear cell renal carcinoma: Significant elevation of IGF2BP2 expression in patients with head and neck squamous cell carcinoma (HNSC) was observed, whereas its expression was decreased in some other cancers, such as breast cancer and renal clear cell carcinoma.